Hanahan, D. & Weinberg, R. Hallmarks of cancer: The next generation. Cell144(5), 646–674 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Fouad, Y. & Aanei, C. Revisiting the hallmarks of cancer. Am. J. Cancer Res.7(5), 1016–1036 (2017).CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Burrell, R., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature501, 338–345 (2013).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Flavahan, W., Gaskell, E. & Bernstein, B. Epigenetic plasticity and the hallmarks of cancer. Science357, 6348 (2017).ArticleÂ
Google ScholarÂ
Yuan, Y. Spatial heterogeneity in the tumor microenvironment. Cold Spring Harb. Perspect. Med.6, a026583 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Marusyk, A. & Polyak, K. Tumor heterogeneity: Causes and consequences. Biochim. Biophys. Acta1805(1), 105 (2010).CASÂ
PubMedÂ
Google ScholarÂ
Gerlinger, M., Rowan, A., Horswell, S., Larkin, J. & Endesfelder, D. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med.366(10), 883–892 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Marusyk, A., Almendro, V. & Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nat. Rev. Cancer12, 323–334 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Swanton, C. Intratumour heterogeneity: Evolution through space and time. Cancer Res.72(19), 4875–4882 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell27, 15–26 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dagogo-Jack, I. & Shaw, A. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol.15, 81–94 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Collins, F. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med.372, 793–795 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Greaves, M. & Maley, C. Clonal evolution in cancer. Nature481, 306–313 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ritchie, M., Holzinger, E., Li, R., Pendergrass, S. & Kim, D. Methods of integrating data to uncover genotype-phenotype interactions. Nat. Rev. Genet.16, 85–97 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Aronson, S. & Rehm, H. Building the foundation for genomics in precision medicine. Nature526, 336–342 (2015).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Young, A., Benonisdottir, S., Przeworski, M. & Kong, A. Deconstructing the sources of genotype-phenotype associations in humans. Science365(6460), 1396–1400 (2019).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kamat, M., Blackshaw, J., Young, R., Surendran, P. & Burgess, S. Phenoscanner v2: An expanded tool for searching human genotype-phenotype associations. Bioinformatics35(22), 4851–4853 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yu, H. & Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst.92, 1472–1489 (2000).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hamidi, H. & Ivaska, J. Every step of the way: Integrins in cancer progression and metastasis. Nat. Rev. Cancer18, 533–548 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schmid, M., Khan, S., Kaneda, P., Pathria, M. M. & Shepard, R. Integrin cd11b activation drives anti-tumor innate immunity. Nat. Commun.9, 5379 (2018).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Song, Q., Hawkins, G., Wudel, L., Chou, P.-C. & Forbes, E. Dissecting intratumoral myeloid cell plasticity by single cell RNA?. Seq. Cancer Med.8, 3072–3085 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Morad, G., Helmink, B., Sharma, P. & Wargo, J. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell184, 5309–5337 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schaafsma, E., Fugle, C., Wang, X. & Cheng, C. Pan-cancer association of hla gene expression with cancer prognosis and immunotherapy efficacy. Br. J. Cancer125, 422–32 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Clevers, H. Modeling development and disease with organoids. Cell7(16), 1586–1597 (2016).ArticleÂ
Google ScholarÂ
Fatehullah, A., Tan, S. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol.18, 246–254 (2016).ArticleÂ
PubMedÂ
Google ScholarÂ
Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer18, 407–418 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J.38, e100300 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Larsen, B. et al. A pan-cancer organoid platform for precision medicine. Cell Rep.36, 109429 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Higa, A. et al. Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis. J. Toxicol. Sci.42, 755–761 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Tamura, H. et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues. Oncol. Rep.40, 635–646 (2018).CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Takahashi, N. et al. An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids. Cells8, 4812019 (2019).ArticleÂ
Google ScholarÂ
Takahashi, N. et al. Construction of in vitro patient?derived tumor models to evaluate anticancer agents and cancer immunotherapy. Oncol. Lett.21(5), 1792–1074 (2021).ArticleÂ
Google ScholarÂ
Higa, A. et al. High-throughput in vitro assay using patient-derived tumor organoids. J. Vis. Exp.14, 172 (2021).
Google ScholarÂ
Rios, A. & Clevers, H. Imaging organoids: A bright future ahead. Nat. Methods15, 24–26 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Borten, M., Bajikar, S., Sasaki, N., Clevers, H. & Janes, K. Automated brightfield morphometry of 3d organoid populations by organoseg. Nat. Methods15, 23 (2018).
Google ScholarÂ
Karolak, A., Poonja, S. & Rejniak, K. Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential. PLoS Comput. Biol.15(7), e1007214 (2019).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Matthews, J. et al. Organoid: A versatile deep learning platform for tracking and analysis of single-organoid dynamics. PLoS Comput. Biol.18(11), e1010584 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Guyon, I., Weston, J., Barnhill, S. & Vapnik, V. Gene selection for cancer classification using support vector machines. Mach. Learn.46, 389–422 (2002).ArticleÂ
Google ScholarÂ
Sawyers, C. The cancer biomarker problem. Nature452, 548–552 (2008).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
LeCun, Y., Bengio, Y. & Hinton, G. Deep learning. Nature521(7553), 436–44 (2015).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hinton, G. & Salakhutdinov, R. Reducing the dimensionality of data with neural networks. Science313(5786), 504–507 (2006).ArticleÂ
ADSÂ
MathSciNetÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hinton, S., Osindero, G. & Teh, Y. A fast learning algorithm for deep belief nets. Neural Computat.18(7), 1527–1554 (2006).ArticleÂ
MathSciNetÂ
Google ScholarÂ
Shorten, C. & Khoshgoftaar, T. A survey on image data augmentation for deep learning. J. Big Data6, 60 (2019).ArticleÂ
Google ScholarÂ
Chandrashekar, G. & Sahin, F. A survey on feature selection methods. Comput. Electr. Eng.40(1), 16–28 (2014).ArticleÂ
Google ScholarÂ
Kraus, O., Ba, J. & Frey, B. Classifying and segmenting microscopy images with deep multiple instance learning. Bioinformatics32(12), i52–i59 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kassis, T., Hernandez-Gordillo, V., Langer, R. & Griffith, L. Orgaquant: Human intestinal organoid localization and quantification using deep convolutional neural network. Sci. Rep.9, 12479 (2019).ArticleÂ
ADSÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chaudhary, K., Poirion, O., Lu, L. & Garmire, L. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin. Cancer Res.24(6), 1248–59 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Li, Y., Wu, F. & Ngom, A. A review on machine learning principles for multi-view biological data integration. Brief. Bioinform.19(2), 325–340 (2018).PubMedÂ
Google ScholarÂ
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M. & Blaschke, T. The rise of deep learning in drug discovery. Drug Discov. Today23(6), 1241–1250 (2018).ArticleÂ
PubMedÂ
Google ScholarÂ
Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med.25, 24–29 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Calon, A. et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet.47, 320–329 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov.18(6), 463–477 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chang, Y. et al. Cancer drug response profile scan (cdrscan): A deep learning model that predicts drug effectiveness from cancer genomic signature. Sci. Rep.8, 8857 (2018).ArticleÂ
ADSÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ